Exscientia is using AI to accelerate the precision design and development of transformational medicines.
Leadership
Andrew Hopkins
Fund
SVF2
Status
NASDAQ: EXAI
Sector
Health Tech
Region
EMEA
Exscientia is using AI to accelerate the precision design and development of transformational medicines.